Fund Holdings — venBio Partners LLC

Total Portfolio Value:
$123.56M
Total Bought:
$0
Total Sold:
$14.04M
Net Transaction:
-$14.04M
Notable People:
Venbio Partners, L.P.
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Pharvaris N V
COM
4,289,3044,289,3040$82.23M$67.34M54.50%-$14.88M
Alumis Inc2,787,3982,787,3980$21.91M$17.11M13.85%-$4.79M
Harmony Biosciences Holdings, Inc.(HRMY)539,194489,194-50,000$18.55M$16.24M13.14%-$2.32M
Acelyrin Inc3,806,4103,806,4100$11.95M$9.40M7.61%-$2.55M
ALX Oncology Holdings Inc.(ALXO)9,699,9259,699,9250$16.20M$6.04M4.89%-$10.16M
Lyell Immunopharma, Inc.(LYEL)7,102,1907,102,1900$4.55M$3.82M3.09%-$724.4K
Artiva Biotherapeutics, Inc.(ARTV)1,519,9711,198,975-320,996$15.32M$3.60M2.91%-$11.72M
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q1 2025 | TickerTrail